---
annotations:
- type: Pathway Ontology
  value: ephrin - ephrin receptor bidirectional signaling axis
authors:
- ReactomeTeam
- Mkutmon
description: 'During the development process cell migration and adhesion are the main
  forces involved in morphing the cells into critical anatomical structures. The ability
  of a cell to migrate to its correct destination depends heavily on signaling at
  the cell membrane. Erythropoietin producing hepatocellular carcinoma (EPH) receptors
  and their ligands, the ephrins (EPH receptors interacting proteins, EFNs), orchestrates
  the precise control necessary to guide a cell to its destination. They are expressed
  in all tissues of a developing embryo and are involved in multiple developmental
  processes such as axon guidance, cardiovascular and skeletal development and tissue
  patterning. In addition, EPH receptors and EFNs are expressed in developing and
  mature synapses in the nervous system, where they may have a role in regulating
  synaptic plasticity and long-term potentiation. Activation of EPHB receptors in
  neurons induces the rapid formation and enlargement of dendritic spines, as well
  as rapid synapse maturation (Dalva et al. 2007). On the other hand, EPHA4 activation
  leads to dendritic spine elimination (Murai et al. 2003, Fu et al. 2007).<br>EPH
  receptors are the largest known family of receptor tyrosine kinases (RTKs), with
  fourteen total receptors divided into either A- or B-subclasses: EPHA (1-8 and 10)
  and EPHB (1-4 and 6). EPH receptors can have overlapping functions, and loss of
  one receptor can be partially compensated for by another EPH receptor that has similar
  expression pattern and ligand-binding specificities. EPH receptors have an N-terminal
  extracellular domain through which they bind to ephrin ligands, a short transmembrane
  domain, and an intracellular cytoplasmic signaling structure containing a canonical
  tyrosine kinase catalytic domain as well as other protein interaction sites. Ephrins
  are also sub-divided into an A-subclass (A1-A5), which are tethered to the plasma
  membrane by a glycosylphosphatidylinositol (GPI) anchor, and a B-subclass (B1-B3),
  members of which have a transmembrane domain and a short, highly conserved cytoplasmic
  tail lacking endogenous catalytic activity. The interaction between EPH receptors
  and its ligands requires cell-cell interaction since both molecules are membrane-bound.
  Close contact between EPH receptors and EFNs is required for signaling to occur.
  EPH/EFN-initiated signaling occurs bi-directionally into either EPH- or EFN-expressing
  cells or axons. Signaling into the EPH receptor-expressing cell is referred as the
  forward signal and signaling into the EFN-expressing cell, the reverse signal. (Dalva
  et al. 2000, Grunwald et al. 2004, Davy & Robbins 2000, Cowan et al. 2004)  View
  original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2682334 Reactome].'
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3309
- /instance/WP3309
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3309.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'During the development process cell migration and adhesion are the
    main forces involved in morphing the cells into critical anatomical structures.
    The ability of a cell to migrate to its correct destination depends heavily on
    signaling at the cell membrane. Erythropoietin producing hepatocellular carcinoma
    (EPH) receptors and their ligands, the ephrins (EPH receptors interacting proteins,
    EFNs), orchestrates the precise control necessary to guide a cell to its destination.
    They are expressed in all tissues of a developing embryo and are involved in multiple
    developmental processes such as axon guidance, cardiovascular and skeletal development
    and tissue patterning. In addition, EPH receptors and EFNs are expressed in developing
    and mature synapses in the nervous system, where they may have a role in regulating
    synaptic plasticity and long-term potentiation. Activation of EPHB receptors in
    neurons induces the rapid formation and enlargement of dendritic spines, as well
    as rapid synapse maturation (Dalva et al. 2007). On the other hand, EPHA4 activation
    leads to dendritic spine elimination (Murai et al. 2003, Fu et al. 2007).<br>EPH
    receptors are the largest known family of receptor tyrosine kinases (RTKs), with
    fourteen total receptors divided into either A- or B-subclasses: EPHA (1-8 and
    10) and EPHB (1-4 and 6). EPH receptors can have overlapping functions, and loss
    of one receptor can be partially compensated for by another EPH receptor that
    has similar expression pattern and ligand-binding specificities. EPH receptors
    have an N-terminal extracellular domain through which they bind to ephrin ligands,
    a short transmembrane domain, and an intracellular cytoplasmic signaling structure
    containing a canonical tyrosine kinase catalytic domain as well as other protein
    interaction sites. Ephrins are also sub-divided into an A-subclass (A1-A5), which
    are tethered to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor,
    and a B-subclass (B1-B3), members of which have a transmembrane domain and a short,
    highly conserved cytoplasmic tail lacking endogenous catalytic activity. The interaction
    between EPH receptors and its ligands requires cell-cell interaction since both
    molecules are membrane-bound. Close contact between EPH receptors and EFNs is
    required for signaling to occur. EPH/EFN-initiated signaling occurs bi-directionally
    into either EPH- or EFN-expressing cells or axons. Signaling into the EPH receptor-expressing
    cell is referred as the forward signal and signaling into the EFN-expressing cell,
    the reverse signal. (Dalva et al. 2000, Grunwald et al. 2004, Davy & Robbins 2000,
    Cowan et al. 2004)  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2682334
    Reactome].'
  keywords:
  - DNM1
  - 'PSEN2(1-297) '
  - 'PAK1 '
  - 'CLTCL1 '
  - HRAS:GTP
  - 'FYN '
  - 'RHOA '
  - 'EPHB2 (19-?) '
  - EPHBs:EFNBs:SRC,FYN
  - TIAM1
  - 'ACTR2 '
  - p-LIMK
  - SRC,FYN
  - f-actin
  - VAV2,VAV3
  - gamma-secretase
  - 'NCSTN '
  - 'EPHB3 (?-998) '
  - GDP
  - EPHB:EFNB:F-actin:AP-2:Clathrrin:Dynamin
  - EFNAs
  - 'p-Y397-PTK2 '
  - EFNAs/EFNBs:p-EPHAs/p-EPHBs:SFKs:VAV2,VAV3
  - 'EPHA1 '
  - 'EPHA7 '
  - EPHB C-terminal
  - 'EFNA2 '
  - 'Class 2 myosins play a crucial role in a variety of cellular processes, including
    cell migration, polarity formation, and cytokinesis. '
  - RHOA:GDP
  - Glu:NMDAR:Gly
  - 'MYH10 '
  - cluster
  - RASA1
  - EPHBs:p-3Y-EFNBs:SRC,FYN:GRB4:p-GIT1:ARHGEF7
  - oligomers
  - 'p-Y173-VAV3 '
  - 'EFNA1(?-182) C-ter '
  - MYL12A
  - 'EPHB1 (18-?) '
  - 'EFNA4 (?-170) C-ter '
  - 'Gly '
  - 'EFNA4 '
  - 'MYL9 '
  - 'HRAS '
  - 'EPHB2 '
  - 'ARPC1A '
  - EPHAs
  - ITSN1
  - 'ACTG1 '
  - 'EPHB1 (?-984) '
  - EFNBs:p-EPHBs:PTK2
  - 'p-Y829-TIAM1 '
  - ROCKs
  - 'p-EPHB:EFNB oligomers '
  - 'CLTA '
  - EPHBs:p-3Y-EFNBs:SRC,FYN:GRB4:p-GIT1
  - 'EPHB6 (?-1021) '
  - H2O
  - 'p-Y311,Y316,Y330-EFNB2 '
  - 'MYH14 '
  - p-S19-MYL12A
  - 'p-Y179-NGEF '
  - 'EPHB:EFNB oligomers '
  - 'EPHB3 '
  - myosin II
  - fragments (CTF)
  - 'p-T508-LIMK1 '
  - 'EPHB4 (?-987) '
  - SDCBP
  - 'EPHA5 '
  - 'GTP '
  - 'p-S141,T402-PAK2 '
  - oligomers:SRC,FYN,YES1,LYN
  - 'AP2A2(1-939) '
  - 'ACTR3 '
  - Pi
  - CDC42:GDP
  - 'p-Y1252,Y1336,Y1474-GRIN2B '
  - 'ARPC2 '
  - 'VAV2 '
  - RAC1:GDP
  - EPHBs:EFNBs
  - 'EPHB1 (?-?) '
  - ARP2/3 complex (ATP
  - 'EFNA1 '
  - 'EFNA3 (?-214) C-ter '
  - EFNBs:p-EPHBs:SFKs:Glu:p-NMDAR:Gly:TIAM1
  - 'EFNA5 (21-?) N-ter '
  - 'ACTB(1-375) '
  - EPHBs:p-3Y-EFNBs:SRC,FYN
  - 'ARPC5 '
  - 'p-T19,S20-MYL12B '
  - 'MMP9(107-707) '
  - 'EFNB1 '
  - 'ARHGEF28 '
  - 'NGEF '
  - 'MYL6 '
  - EPHBs:EFNBs:SDCBP
  - 'f-actin '
  - p-EPHB:EFNB
  - EFNAs/EFNBs:p-EPHAs/p-EPHBs:SFKs:p-VAV2,VAV3
  - 'GDP '
  - PAK1 dimer
  - 'ITSN1 '
  - Smooth
  - 'EFNA2 (25-?) N-ter '
  - RAC1-GTP:p-S144,T423-PAK1
  - 'ATP '
  - SRC,FYN,YES,LYN
  - 'GRIN1 '
  - MMP2, MMP9
  - 'EPHA6 '
  - EFNBs:p-EPHBs:SFKs:Glu:p-NMDAR:Gly:p-Y829-TIAM1
  - EPHBs:p-3Y-EFNBs:SRC,FYN:GRB4
  - 'EPHA:EFNA oligomers '
  - 'AP2M1 '
  - 'PAK3 '
  - 'EPHB6 (?-?) '
  - 'EFNA3 '
  - EPH-EFN dimers
  - PTK2
  - p-Y179,Y191-SDC2
  - 'GRIN2B '
  - RHOA:GTP
  - 'p-T19,S20-MYL9 '
  - 'PSEN1(299-467) '
  - 'EPHB2 (?-1055) '
  - ROCK1,ROCK2
  - RAC1:GTP:PAK1
  - 'EPHA10 '
  - PI(4,5)P2
  - LIM Kinases
  - EFNBs:p-EPHBs:p-Y397-PTK2:ARHGEF28
  - 'EFNA5 (?-203) C-ter '
  - Clathrin
  - 'EPHA8 '
  - GTP
  - EFNAs:p-EPHAs:SFKs:NGEF
  - 'p-EPHA:EFNA oligomers '
  - EPHBs
  - 'ARPC1B '
  - GIT1
  - 'PSEN1(1-298) '
  - 'ARHGEF7 '
  - 'L-Glu '
  - 'EFNA1 (19-?) N-ter '
  - 'PTK2 '
  - 'MYH11 '
  - p-EPHBs:EFNBs:ITSN1:N-WASP:CDC42:GTP:PI(4,5)P2:ARP2/3;G-actin
  - ADAM10
  - 'EPHB4 '
  - 'EPHA3 '
  - fragments
  - dimer:RAC1:GTP
  - muscle/non-muscle
  - 'EPHB6 (32-?) '
  - EFNBs:p-EPHBs:SFKs:Glu:p-NMDAR:Gly
  - EFNAs:p-EPHAs:SFKs
  - bound)
  - EPHAs:EFNAs,EPHBs:EFNBs
  - 'SDCBP '
  - 'EFNA4 (26-?) N-ter '
  - 'LYN '
  - 'APH1A '
  - EPHB CTF2
  - 'N-WASP '
  - 'RASA1 '
  - 'EPHA2 '
  - AP-2 Complex
  - p-EPHBs:EFNBs:RASA1:HRAS:GTP
  - EPHBs:p-3Y-EFNBs:SRC,FYN:GRB4:p-GIT1:ARHGEF7:RAC1:GTP:p-PAK1,3
  - 'EFNB3 '
  - PAK1/3, 2
  - N-WASP
  - p-Y383-GIT1
  - 'GGC-PalmC-RAC1 '
  - p-EPHBs:EFNBs:RASA1
  - 'ARPC3 '
  - p-EPHBs:EFNBs:RASA1:HRAS:GDP
  - 'AP2B1 '
  - 'p-T505-LIMK2 '
  - 'ROCK2 '
  - 'ROCK1 '
  - EFNBs
  - 'MYL12B '
  - EPHAs:EFNAs:ADAM10
  - EFNBs:p-EPHBs:SFKs
  - p-EPHBs:EFNBs:ITSN1
  - 'PI(4,5)P2 '
  - RHO GTPases Activate
  - ATP
  - p-EPHBs:EFNBs:ITSN1:N-WASP:CDC42:GTP
  - 'NCK2 '
  - 'DNM1 '
  - 'TIAM1 '
  - complex
  - EFNA C-terminal
  - NGEF
  - ADP
  - 'CDC42 '
  - 'EFNA5 '
  - ARHGEF28
  - 'EPHB3 (?-?) '
  - 'p-S154,T436-PAK3 '
  - p-EPH:ephrin
  - 'EPHB6 '
  - 'PSENEN '
  - 'MYH9 '
  - EFNAs:p-EPHAs:SFKs:TIAM1
  - 'MMP2(110-660) '
  - 'ARPC4 '
  - 'EPHB1 '
  - p-S3-CFL1
  - CFL1
  - 'p-S144,T423-PAK1 '
  - EFNA N-terminal
  - 'CLTC '
  - 'APH1B '
  - 'PAK2 '
  - 'ADAM10 '
  - 'VAV3 '
  - 'EPHB3 (34-?) '
  - 'KALRN '
  - EPHB CTF1
  - 'PSEN2(298-448) '
  - 'YES1 '
  - EFNBs:p-EPHBs:p-Y397-PTK2
  - 'EFNA2 (?-188) C-ter '
  - EFNAs:p-EPHAs:SFKs:p-Y179-NGEF
  - 'SRC-1 '
  - EPHBs:p-3Y-EFNBs:SRC,FYN:GRB4:p-GIT1:ARHGEF7:RAC1:GTP
  - 'EFNA3 (23-?) N-ter '
  - 'p-Y172-VAV2 '
  - 'EPHB4 (?-?) '
  - 'p-Y383-GIT1 '
  - 'RAC1 '
  - 'EPHA4 '
  - EFNBs:p-EPHBs:KALRN
  - EPHBs:p-3Y-EFNBs:SRC,FYN:GRB4:p-GIT1:ARHGEF7:RAC1:GTP:PAK1,3
  - KALRN
  - EPHB N-terminal
  - 'AP2S1 '
  - 'p-Y318,Y323,Y337-EFNB3 '
  - 'AP2A1 '
  - 'EFNB2 '
  - p-EPHBs:EFNBs:ITSN1:N-WASP:CDC42:GTP:PI(4,5)P2
  - SDC2
  - NCK2
  - 'LIMK1 '
  - 'LIMK2 '
  - p-EPHBs:EFNBs:ITSN1:N-WASP
  - EPH-ephrin oligomers
  - RHOA:GTP:ROCK1,ROCK2
  - EFNBs:p-EPHBs:SFKs:Glu:NMDAR:Gly
  - RAC1:GTP
  - 'CLTB '
  - ARHGEF7
  - 'EPHB2 (?-?) '
  - G-actin
  - 'EPHB4 (16-?) '
  - EPHAs:EFNAs
  - 'p-Y324,Y329,Y343-EFNB1 '
  - p-T19,S20-MRLC-smooth muscle/non-muscle myosin II
  license: CC0
  name: EPH-Ephrin signaling
seo: CreativeWork
title: EPH-Ephrin signaling
wpid: WP3309
---